Ajanta Pharma Ltd releases Consolidated Financial Results for December 31, 2022.
Financial Results (Q3 FY2023) – Quarter-over-Quarter Comparison:
Total income of Ajanta Pharma Ltd is Rs.1006.70 Crores (December 31, 2022) vs. Rs.978.45 Crores (September 30, 2022)
Net profit/loss: Rs.134.51 Crores (December 31, 2022) vs. Rs.156.60 Crores (September 30, 2022)
EPS: Rs.10.50 (December 31, 2022) vs. Rs.12.22 (September 30, 2022)
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹1006.70 Cr | ₹978.45 Cr | ⬆ 2.89% |
| Net Profit | ₹134.51 Cr | ₹156.60 Cr | ⬇ -14.11 |
| EPS | ₹10.50 | ₹12.22 | ⬇ -14.08% |
Financial Results (Q3 FY2023) – Year-over-Year Comparison:
Total income of Ajanta Pharma Ltd is Rs.1006.70 Crores (December 31, 2022) vs. Rs.861.94 Crores (December 31, 2022)
Net profit/loss: Rs.134.51 Crores (December 31, 2022) vs. Rs.191.78 Crores (December 31, 2022)
EPS: Rs.10.50 (December 31, 2022) vs. Rs.14.77 (December 31, 2022)
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹1006.70 Cr | ₹861.94 Cr | ⬆ 16.79% |
| Net Profit | ₹134.51 Cr | ₹191.78 Cr | ⬇ -28.86% |
| EPS | ₹10.50 | ₹14.77 | ⬇ -28.91% |
Financial Results (9 Months Ended FY2023) – Year-over-Year Comparison:
Total income of Ajanta Pharma Ltd is Rs.2968.84 Crores (December 31, 2022) vs. Rs.2556.90 Crores (December 31, 2021)
Net profit/loss: Rs.465.73 Crores (December 31, 2022) vs. Rs.561.47 Crores (December 31, 2021)
EPS: Rs.36.35 (December 31, 2022) vs. Rs.43.26 (December 31, 2021)
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹2968.84 Cr | ₹2556.90 Cr | ⬆ 16.11% |
| Net Profit | ₹465.73 Cr | ₹561.47 Cr | ⬇ -17.05% |
| EPS | ₹36.35 | ₹43.26 | ⬇ -15.97% |
For More Latest News Click Here
